BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a protein naturally found in human gastric juice. It is widely studied in preclinical research for its role in tissue repair, angiogenesis, and cytoprotective signalling.

How do I reconstitute BPC-157?

Reconstitute with 1-2 ml of bacteriostatic water. Allow the vial to reach room temperature, inject solvent gently down the inside wall, and swirl gently. Never shake. Store reconstituted solution at 2-8°C and use within 4-6 weeks.

What purity is BioLab's BPC-157?

Every batch is independently tested via HPLC and mass spectrometry to confirm 99%+ purity and correct molecular identity. A batch-specific Certificate of Analysis is available with every order.

How should I store BPC-157?

Store lyophilised vials at -20°C, protected from light and moisture. Once reconstituted with bacteriostatic water, store at 2-8°C and use within 4-6 weeks. Avoid repeated freeze-thaw cycles.

MOD GRF 5 mg

£20.00

MOD GRF (Modified GRF 1-29) is a synthetic 29-amino-acid GHRH analogue with four amino acid substitutions for DPP-IV resistance. Identical compound to CJC-1295 without DAC. Available to buy in the UK from BioLab Peptides – 5 mg, 99%+ purity.

Purity: ≥99% (HPLC & MS)
Quantity: 5 mg per vial
CAS: 863288-34-0
Amino Acids: 29 (modified GHRH 1-29)
Storage: -20°C (lyophilised) · 2-8°C (reconstituted)

Categories: All Peptides, Growth Hormone Secretagogues

Description
Reviews (0)

MOD GRF 5 mg – Modified GRF 1-29 (CJC-1295 no DAC)

MOD GRF (Modified GRF 1-29) is the same compound as CJC-1295 without DAC, listed under its alternative name for researchers who search by this designation. It is a 29-amino-acid synthetic analogue of endogenous GHRH with four amino acid substitutions (Ala2, Ala8, Ala15, Leu27) that confer resistance to DPP-IV enzymatic degradation.

Research Background

Pulsatile GH stimulation – MOD GRF activates the GHRH receptor on pituitary somatotrophs to produce pulsatile growth hormone release that preserves the natural secretory rhythm and feedback loop.

Synergistic stacking – MOD GRF is most commonly studied alongside GHS-R agonists such as Ipamorelin or GHRP-2. The combination of GHRH-R and GHS-R activation produces synergistic GH release greater than either pathway alone.

Pre-mixed blends available – For convenience, we offer Ipamorelin + MOD GRF Blend (3/3 mg) and GHRP-2 + MOD GRF Blend (5/5 mg).